How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

10,985 results for

General Medical Books

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Nivolumab (urothelial carcinoma) - Benefit assessment according to §35a Social Code Book V

Nivolumab (urothelial carcinoma) - Benefit assessment according to §35a Social Code Book V Extract 1 Translation of Sections 2.1 to 2.6 of the dossier assessment Nivolumab (Urothelkarzinom) – Nutzenbewertung gemäß § 35a SGB V (Version 1.0; Status: 28 September 2017). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. IQWiG Reports – Commission No. A17-29 Nivolumab (...) (urothelial carcinoma) – Benefit assessment according to §35a Social Code Book V 1 Extract of dossier assessment A17-29 Version 1.0 Nivolumab (urothelial carcinoma) 28 September 2017 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Nivolumab (urothelial carcinoma) – Benefit assessment according to §35a Social Code Book V Commissioning agency: Federal Joint Committee Commission awarded on: 3 July 2017

2017 Institute for Quality and Efficiency in Healthcare (IQWiG)

82. Dabrafenib (non-small cell lung cancer) - Benefit assessment according to §35a Social Code Book V

Dabrafenib (non-small cell lung cancer) - Benefit assessment according to §35a Social Code Book V Extract 1 Translation of Sections 2.1 to 2.5 of the dossier assessment Dabrafenib (nicht kleinzelliges Lungenkarzinom) – Nutzenbewertung gemäß § 35a SGB V (Version 1.0; Status: 28 July 2017). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. IQWiG Reports – Commission (...) No. A17-17 Dabrafenib (non-small cell lung cancer) – Benefit assessment according to §35a Social Code Book V 1 Extract of dossier assessment A17-17 Version 1.0 Dabrafenib (non-small cell lung cancer) 28 July 2017 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Dabrafenib (non-small cell lung cancer) – Benefit assessment according to §35a Social Code Book V Commissioning agency: Federal Joint

2017 Institute for Quality and Efficiency in Healthcare (IQWiG)

83. Osimertinib (NSCLC) - Benefit assessment according to §35a Social Code Book V

Osimertinib (NSCLC) - Benefit assessment according to §35a Social Code Book V Extract 1 Translation of Sections 2.1 to 2.5 of the dossier assessment Osimertinib (nicht kleinzelliges Lungenkarzinom) – Nutzenbewertung gemäß § 35a SGB V (Version 1.0; Status: 28 July 2017). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. IQWiG Reports – Commission No. A17-20 (...) Osimertinib (non-small cell lung cancer) – Benefit assessment according to §35a Social Code Book V 1 (expiry of the limitation period) Extract of dossier assessment A17-20 Version 1.0 Osimertinib (non-small cell lung cancer) 28 July 2017 Institute for Quality and Efficiency in Health Care (IQWiG) - 1 - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Osimertinib (non-small cell lung cancer) – Benefit assessment according to §35a Social Code Book V Commissioning

2017 Institute for Quality and Efficiency in Healthcare (IQWiG)

84. Nivolumab (squamous cell carcinoma of the head and neck) - Benefit assessment according to §35a Social Code Book V

Nivolumab (squamous cell carcinoma of the head and neck) - Benefit assessment according to §35a Social Code Book V Extract 1 Translation of Sections 2.1 to 2.6 of the dossier assessment Nivolumab (Plattenepithelkarzinom des Kopf-Hals- Bereichs) – Nutzenbewertung gemäß § 35a SGB V (Version 1.0; Status: 30 August 2017). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally (...) binding. IQWiG Reports – Commission No. A17-24 Nivolumab (squamous cell carcinoma of the head and neck) – Benefit assessment according to §35a Social Code Book V 1 Extract of dossier assessment A17-24 Version 1.0 Nivolumab (squamous cell carcinoma of the head and neck) 30 August 2017 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Nivolumab (squamous cell carcinoma of the head and neck) – Benefit

2017 Institute for Quality and Efficiency in Healthcare (IQWiG)

85. Rolapitant (prevention of nausea and vomiting in chemotherapy) - Benefit assessment according to §35a Social Code Book V

Rolapitant (prevention of nausea and vomiting in chemotherapy) - Benefit assessment according to §35a Social Code Book V Extract 1 Translation of Sections 2.1 to 2.6 of the dossier assessment Rolapitant (Prävention von Übelkeit und Erbrechen bei Chemotherapie) – Nutzenbewertung gemäß § 35a SGB V (Version 1.0; Status: 30 August 2017). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative (...) and legally binding. IQWiG Reports – Commission No. A17-26 Rolapitant (prevention of nausea and vomiting in chemotherapy) – Benefit assessment according to §35a Social Code Book V 1 Extract of dossier assessment A17-26 Version 1.0 Rolapitant (prevention of nausea and vomiting in chemotherapy) 30 August 2017 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Rolapitant (prevention of nausea and vomiting

2017 Institute for Quality and Efficiency in Healthcare (IQWiG)

86. Alectinib (NSCLC) - Benefit assessment according to §35a Social Code Book V

Alectinib (NSCLC) - Benefit assessment according to §35a Social Code Book V Extract 1 Translation of Sections 2.1 to 2.5 of the dossier assessment Alectinib (nicht kleinzelliges Lungenkarzinom) – Nutzenbewertung gemäß § 35a SGB V (Version 1.0; Status: 28 July 2017). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. IQWiG Reports – Commission No. A17-19 Alectinib (...) (non-small cell lung cancer) – Benefit assessment according to §35a Social Code Book V 1 Extract of dossier assessment A17-19 Version 1.0 Alectinib (non-small cell lung cancer) 28 July 2017 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Alectinib (non-small cell lung cancer) – Benefit assessment according to §35a Social Code Book V Commissioning agency: Federal Joint Committee Commission

2017 Institute for Quality and Efficiency in Healthcare (IQWiG)

87. Nivolumab (melanoma) - Benefit assessment according to §35a Social Code Book V (expiry of the decision)

Nivolumab (melanoma) - Benefit assessment according to §35a Social Code Book V (expiry of the decision) Extract 1 Translation of Sections 2.1 to 2.6 of the dossier assessment Nivolumab (Melanom) – Nutzenbewertung gemäß § 35a SGB V (Version 1.0; Status: 13 September 2017). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. IQWiG Reports – Commission No. A17-27 (...) Nivolumab (melanoma) – Benefit assessment according to §35a Social Code Book V 1 (expiry of the decision) Extract of dossier assessment A17-27 Version 1.0 Nivolumab (melanoma) 13 September 2017 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Nivolumab (melanoma) – Benefit assessment according to §35a Social Code Book V Commissioning agency: Federal Joint Committee Commission awarded on: 15 June

2017 Institute for Quality and Efficiency in Healthcare (IQWiG)

88. Ceritinib (non-small cell lung cancer) ? Benefit assessment according to §35a Social Code Book V

Ceritinib (non-small cell lung cancer) ? Benefit assessment according to §35a Social Code Book V Extract 1 Translation of Sections 2.1 to 2.6 of the dossier assessment Ceritinib (nicht kleinzelliges Lungenkarzinom) – Nutzenbewertung gemäß § 35a SGB V (Version 1.0; Status: 25 October 2017). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. IQWiG Reports (...) – Commission No. A17-32 Ceritinib (non-small cell lung cancer) – Benefit assessment according to §35a Social Code Book V 1 Extract of dossier assessment A17-32 Version 1.0 Ceritinib (non-small cell lung cancer) 25 October 2017 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Ceritinib (non-small cell lung cancer) – Benefit assessment according to §35a Social Code Book V Commissioning agency: Federal

2017 Institute for Quality and Efficiency in Healthcare (IQWiG)

89. Dr. Kelly Brogan’s e-book “Vaccines and Brain Health”: A cornucopia of antivaccine misinformation and pseudoscience

Dr. Kelly Brogan’s e-book “Vaccines and Brain Health”: A cornucopia of antivaccine misinformation and pseudoscience Dr. Kelly Brogan's e-book "Vaccines and Brain Health": A cornucopia of antivaccine misinformation and pseudoscience - RESPECTFUL INSOLENCE March 27, 2019 March 25, 2019 March 22, 2019 March 20, 2019 March 19, 2019 March 18, 2019 Athaic on Anthony on Eric Lund on Denice Walter on squirrelelite on Derek Freyberg on RJ on RJ on RJ on RJ on rs on Search and explore Browse "A statement (...) of fact cannot be insolent." The miscellaneous ramblings of a surgeon/scientist on medicine, quackery, science, and pseudoscience (and anything else that interests him). Dr. Kelly Brogan’s e-book “Vaccines and Brain Health”: A cornucopia of antivaccine misinformation and pseudoscience Last week, I how Gwyneth Paltrow and Goop had doubled down on quackery and antivaccine misinformation by featuring “holistic psychiatrist” Dr. Kelly Brogan as one of the keynote speakers and prominent panelists at its

2017 Respectful Insolence

90. My new book is out today. Here is the introduction. Hooray!

My new book is out today. Here is the introduction. Hooray! My new book is out today. Here is the introduction. Hooray! – Bad Science Search TED Talk Collected Journalism This Nerdy Book This Great Book T-shirts Categories (3) (4) (6) (45) (28) (6) (16) (190) (5) (20) (52) (88) (2) (1) (2) (1) (677) (4) (14) (2) (37) (4) (9) (3) (11) (6) (3) (16) (13) (1) (6) (8) (6) (6) (3) (13) (2) (2) (27) (1) (2) (6) (1) (7) (8) (3) (1) (4) (12) (1) (3) (20) (2) (13) (1) (20) (15) (4) (1) (20) (1) (1) (1 (...) ) (1) (5) (1) (10) (1) (2) (1) (1) (6) (4) (3) (2) (52) (3) (18) (10) (1) October 23rd, 2014 by Ben Goldacre in , , | My new book is out today: a collection of columns, journalism and essays, but also some of my more colourful government reports, academic papers, and more. It looks lovely. Here is the introduction. Hooray! …… ………………….. …………………. ……… ………. ………. ….. …………………….. ………. …………………. …….. ……….. Introduction This is a collection of my most fun fights: but the fighting is just an excuse. There’s

2014 Bad Science

91. Why do patients seek primary medical care in emergency departments? An ethnographic exploration of access to general practice. (PubMed)

Why do patients seek primary medical care in emergency departments? An ethnographic exploration of access to general practice. To describe how processes of primary care access influence decisions to seek help at the emergency department (ED).Ethnographic case study combining non-participant observation, informal and formal interviewing.Six general practitioner (GP) practices located in three commissioning organisations in England.Reception areas at each practice were observed over the course (...) of a working week (73 hours in total). Practice documents were collected and clinical and non-clinical staff were interviewed (n=19). Patients with recent ED use, or a carer if aged 16 and under, were interviewed (n=29).Past experience of accessing GP care recursively informed patient decisions about where to seek urgent care, and difficulties with access were implicit in patient accounts of ED use. GP practices had complicated, changeable systems for appointments. This made navigating appointment booking

Full Text available with Trip Pro

2017 BMJ open

92. 2015 Samuel Johnson Prize Goes to NeuroTribes, by Steve Silberman – First science book to win UK’s top nonfiction book award

organization in the world, Autism Speaks. It makes me think that it’s very important to understand the history of disability to understand the history of autism: We are so used to looking at autism as this isolated medical condition and not looking at it in a social context. The thing that I tried to do most of all in my book was to situate autism and autism research in its historical context. I’ll give you an example: How many times have we read about Asperger’s syndrome without being told that Hans (...) was autistic. He wrote a dozen books that only he would read; he never intended anyone else to read them. They were extensively crossed referenced, they were written in Hebrew, and they were books about Jewish law. And his father was socially inept and generally kept to himself, and Kanner sort of charmingly described those books as his father’s way of playing solitaire. Yet Kanner’s mother, whom he called Klara the Cossack, was clearly hyper-neurotypical and was very aware of what people thought about her

2015 PLOS Blogs Network

93. Measuring the Impact of the French Version of the Whiplash Book

Measuring the Impact of the French Version of the Whiplash Book Measuring the Impact of the French Version of the Whiplash Book - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Measuring the Impact (...) of the French Version of the Whiplash Book (WHIPLASH) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03040245 Recruitment Status : Completed First Posted : February 2, 2017 Last Update Posted : February 2, 2017 Sponsor: University Hospital, Clermont-Ferrand Collaborators: CH Aurillac Jacques Lacarin

2017 Clinical Trials

94. “Imaging in Sports-Specific Musculoskeletal Injuries”- Book review by K.M. Khan and H. Chalabi

are, of course, included but you can also learn about the imaging of rodeo and climbing sports injuries, for example. Sporting focus!! The first wave of sports medicine books were anatomically-oriented and very surgical. The next generation was symptom-oriented and much more multidisciplinary. There have been very few ‘sport-focused’ books and no single book springs to mind as a ‘must have’. The International Olympic Committee has published a comprehensive series of encyclopedias and manuals on a sport (...) “Imaging in Sports-Specific Musculoskeletal Injuries”- Book review by K.M. Khan and H. Chalabi Imaging in Sports-Specific Musculoskeletal Injuries | BJSM blog - social media's leading SEM voice by By Karim Khan ( ) and Hakim Chalabi (This blog is based on the published preface for the book – it’s not a new piece of writing. Think of BJSM going green – re-use, refresh, re-edit (a bit)). Wow!!! Wow!!! Wow!! As experienced sports physicians we have seen most of the injuries, we have listened

2016 British Journal of Sports Medicine Blog

95. Distance Running Part II: Landmark Research Projects and Science-Based Books

Science by Owen Anderson (18). These authors, all venerated authorities, share an uncommon blend of attributes. Each is a highly-regarded scientist, accomplished athlete, sought-after coach/adviser, and superb writer for professional and general audiences alike. These books connect the dots between science, training and performance, with sage advice and fascinating stories of runners and races. ************************* Phil Sparling is a Professor Emeritus of applied physiology at the Georgia (...) Distance Running Part II: Landmark Research Projects and Science-Based Books Distance Running Part II: Landmark Research Projects and Science-Based Books | BJSM blog - social media's leading SEM voice by By Phillip B. Sparling In , I featured pioneer researchers in distance running. In part II, I’ll first flashback to two notable projects on elite runners, and then share thoughts about books on the science of running. 40 Years Ago – Elite Men’s Project: In 1975, Michael Pollock, director

2016 British Journal of Sports Medicine Blog

96. Self-help Books for Social Anxiety

), cognitive restructuring, situational exposure, exposure to physical symptoms, and maintenance/consolidation. The book also includes a chapter on motivation and treatment options and a chapter on medication, but these were omitted in a previous trial of the book and will also be omitted in the present study. There is also a chapter on social skills, which will be omitted in order to keep dosage similar between the two books. The book briefly mentions acceptance in the context of exposure (e.g., fear (...) Self-help Books for Social Anxiety Self-help Books for Social Anxiety - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Self-help Books for Social Anxiety The safety and scientific validity of this study

2017 Clinical Trials

97. Books: Refuge: Transforming a Broken Refugee System: A New Approach to Refugees (PubMed)

Books: Refuge: Transforming a Broken Refugee System: A New Approach to Refugees 28546411 2018 06 01 1478-5242 67 659 2017 06 The British journal of general practice : the journal of the Royal College of General Practitioners Br J Gen Pract Books: Refuge: Transforming a Broken Refugee System : A New Approach to Refugees. 274 10.3399/bjgp17X691241 Nyiri Polly P Health Inclusion Clinic, Guy's and St Thomas' Hospital NHS Foundation Trust, London. E-mail: pollynyiri@nhs.net. Clare Gerry G Chief (...) Medical Officer (interim), St John's Eye Hospital, Jerusalem. eng Journal Article England Br J Gen Pract 9005323 0960-1643 2017 5 27 6 0 2017 5 27 6 0 2017 5 27 6 1 ppublish 28546411 67/659/274 10.3399/bjgp17X691241 PMC5442946

Full Text available with Trip Pro

2017 The British Journal of General Practice

98. Books: Night Shift: Dragons of Depression to Seabirds (PubMed)

Books: Night Shift: Dragons of Depression to Seabirds 28751345 2018 08 01 1478-5242 67 661 2017 08 The British journal of general practice : the journal of the Royal College of General Practitioners Br J Gen Pract Books: Night Shift: Dragons of Depression to Seabirds. 367 10.3399/bjgp17X692033 Alderson Sarah S University of Leeds, Leeds; salaried GP, Springhall Medical Practice, Halifax. E-mail: s.l.alderson@leeds.ac.uk. eng Journal Article England Br J Gen Pract 9005323 0960-1643 2017 7 29 6 0

Full Text available with Trip Pro

2017 The British Journal of General Practice

99. Books: Academic Diary: Or Why Higher Education Still Matters: Don’t Make Grades Your Only Goal (PubMed)

Books: Academic Diary: Or Why Higher Education Still Matters: Don’t Make Grades Your Only Goal 28034945 2017 07 18 2018 01 01 1478-5242 67 654 2017 01 The British journal of general practice : the journal of the Royal College of General Practitioners Br J Gen Pract Books: Academic Diary: Or Why Higher Education Still Matters: Don't Make Grades Your Only Goal. 34 10.3399/bjgp17X688729 Jeffrey David D Department of Primary Palliative Care, University of Edinburgh, Medical School, Teviot Place

Full Text available with Trip Pro

2017 The British Journal of General Practice

100. Books: Against Empathy: the Case for Rational Compassion: Forming a Bridge (PubMed)

Books: Against Empathy: the Case for Rational Compassion: Forming a Bridge 28963424 2018 10 02 1478-5242 67 663 2017 10 The British journal of general practice : the journal of the Royal College of General Practitioners Br J Gen Pract Books: Against Empathy: the Case for Rational Compassion: Forming a Bridge. 468 10.3399/bjgp17X692921 Jeffrey David D Department of Primary Palliative Care, University of Edinburgh, Medical School, Teviot Place, Edinburgh. E-mail: D.I.Jeffrey@sms.ed.ac.uk. eng

Full Text available with Trip Pro

2017 The British Journal of General Practice

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>